Canagliflozin during stroke clot removal
Treatments studied
Part of Infections clinical trials.
This trial tests whether giving canagliflozin, a diabetes medication, during clot removal for stroke can improve recovery. It may help protect the brain after a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had an acute ischemic stroke (a blocked blood vessel in the brain).
- You are planning to have a procedure to remove the blood clot from your brain (mechanical thrombectomy).
- You do not have severe kidney disease (stage 4 or 5) and are not on dialysis.
- You have not taken an SGLT2 inhibitor medication (such as canagliflozin) in the last 3 months.
- You are not allergic to canagliflozin.
- You do not have type 1 diabetes and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called endovascular thrombectomy (clot removal through a catheter) for people with very large strokes. It aims to see if removing the clot can help even when a large part of the brain is already damaged.
This trial tests if a diabetes drug called empagliflozin can help the heart's left atrium work better in people who have had a stroke with no known cause. You may join if you are getting a heart monitor device implanted to look for hidden irregular heartbeats.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests whether a medicine called an SGLT2 inhibitor, which is usually used for diabetes, can help protect the brain and improve recovery when given soon after a stroke. It is for people who had a stroke within the last 3 days and have moderate to severe symptoms.
This trial tests whether a medication commonly used for diabetes can help patients who had a stroke due to a blocked large artery in the brain. The drug is given as an injection after the standard procedure to remove the blood clot, and researchers will see if it leads to better recovery.
This study tests whether the drug canagliflozin (a type of diabetes medicine) is safe and works in people on dialysis. It may help improve fluid balance or blood sugar control in hemodialysis patients.
Hear when a new Acute Ischemic Stroke From Large Vessel Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.